Prostate cancer early detection, version 2.2015

Clinical practice guidelines in oncology

Peter R. Carroll, J. Kellogg Parsons, Gerald Andriole, Robert R. Bahnson, Daniel A. Barocas, Erik P. Castle, William J. Catalona, Douglas M. Dahl, John W. Davis, Jonathan I. Epstein, Ruth B. Etzioni, Thomas Farrington, George P. Hemstreet, Mark H. Kawachi, Paul H. Lange, Kevin R. Loughlin, William Lowrance, Paul Maroni, James Mohler, Todd M. Morgan & 11 others Robert B. Nadler, Michael Poch, Chuck Scales, Terrence M. Shaneyfelt, Marc C. Smaldone, Geoffrey Sonn, Preston Sprenke, Andrew J. Vickers, Robert Wake, Dorothy A. Shead, Deborah Freedman-Cass

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Prostate cancer represents a spectrum of disease that ranges from nonaggressive, slow-growing disease that may not require treatment to aggressive, fast-growing disease that does. The NCCN Guidelines for Prostate Cancer Early Detection provide a set of sequential recommendations detailing a screening and evaluation strategy for maximizing the detection of prostate cancer that is potentially curable and that, if left undetected, represents a risk to the patient. The guidelines were developed for healthy men who have elected to participate in the early detection of prostate cancer, and they focus on minimizing unnecessary procedures and limiting the detection of indolent disease.

Original languageEnglish (US)
Pages (from-to)1534-1561
Number of pages28
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume13
Issue number12
DOIs
StatePublished - Dec 1 2015

Fingerprint

Practice Guidelines
Prostatic Neoplasms
Guidelines
Unnecessary Procedures
Early Detection of Cancer
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

Carroll, P. R., Parsons, J. K., Andriole, G., Bahnson, R. R., Barocas, D. A., Castle, E. P., ... Freedman-Cass, D. (2015). Prostate cancer early detection, version 2.2015: Clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network, 13(12), 1534-1561. https://doi.org/10.6004/jnccn.2015.0181

Prostate cancer early detection, version 2.2015 : Clinical practice guidelines in oncology. / Carroll, Peter R.; Parsons, J. Kellogg; Andriole, Gerald; Bahnson, Robert R.; Barocas, Daniel A.; Castle, Erik P.; Catalona, William J.; Dahl, Douglas M.; Davis, John W.; Epstein, Jonathan I.; Etzioni, Ruth B.; Farrington, Thomas; Hemstreet, George P.; Kawachi, Mark H.; Lange, Paul H.; Loughlin, Kevin R.; Lowrance, William; Maroni, Paul; Mohler, James; Morgan, Todd M.; Nadler, Robert B.; Poch, Michael; Scales, Chuck; Shaneyfelt, Terrence M.; Smaldone, Marc C.; Sonn, Geoffrey; Sprenke, Preston; Vickers, Andrew J.; Wake, Robert; Shead, Dorothy A.; Freedman-Cass, Deborah.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 13, No. 12, 01.12.2015, p. 1534-1561.

Research output: Contribution to journalArticle

Carroll, PR, Parsons, JK, Andriole, G, Bahnson, RR, Barocas, DA, Castle, EP, Catalona, WJ, Dahl, DM, Davis, JW, Epstein, JI, Etzioni, RB, Farrington, T, Hemstreet, GP, Kawachi, MH, Lange, PH, Loughlin, KR, Lowrance, W, Maroni, P, Mohler, J, Morgan, TM, Nadler, RB, Poch, M, Scales, C, Shaneyfelt, TM, Smaldone, MC, Sonn, G, Sprenke, P, Vickers, AJ, Wake, R, Shead, DA & Freedman-Cass, D 2015, 'Prostate cancer early detection, version 2.2015: Clinical practice guidelines in oncology', JNCCN Journal of the National Comprehensive Cancer Network, vol. 13, no. 12, pp. 1534-1561. https://doi.org/10.6004/jnccn.2015.0181
Carroll, Peter R. ; Parsons, J. Kellogg ; Andriole, Gerald ; Bahnson, Robert R. ; Barocas, Daniel A. ; Castle, Erik P. ; Catalona, William J. ; Dahl, Douglas M. ; Davis, John W. ; Epstein, Jonathan I. ; Etzioni, Ruth B. ; Farrington, Thomas ; Hemstreet, George P. ; Kawachi, Mark H. ; Lange, Paul H. ; Loughlin, Kevin R. ; Lowrance, William ; Maroni, Paul ; Mohler, James ; Morgan, Todd M. ; Nadler, Robert B. ; Poch, Michael ; Scales, Chuck ; Shaneyfelt, Terrence M. ; Smaldone, Marc C. ; Sonn, Geoffrey ; Sprenke, Preston ; Vickers, Andrew J. ; Wake, Robert ; Shead, Dorothy A. ; Freedman-Cass, Deborah. / Prostate cancer early detection, version 2.2015 : Clinical practice guidelines in oncology. In: JNCCN Journal of the National Comprehensive Cancer Network. 2015 ; Vol. 13, No. 12. pp. 1534-1561.
@article{c2b650ccf6f5457cb119f6ad72a1d7cb,
title = "Prostate cancer early detection, version 2.2015: Clinical practice guidelines in oncology",
abstract = "Prostate cancer represents a spectrum of disease that ranges from nonaggressive, slow-growing disease that may not require treatment to aggressive, fast-growing disease that does. The NCCN Guidelines for Prostate Cancer Early Detection provide a set of sequential recommendations detailing a screening and evaluation strategy for maximizing the detection of prostate cancer that is potentially curable and that, if left undetected, represents a risk to the patient. The guidelines were developed for healthy men who have elected to participate in the early detection of prostate cancer, and they focus on minimizing unnecessary procedures and limiting the detection of indolent disease.",
author = "Carroll, {Peter R.} and Parsons, {J. Kellogg} and Gerald Andriole and Bahnson, {Robert R.} and Barocas, {Daniel A.} and Castle, {Erik P.} and Catalona, {William J.} and Dahl, {Douglas M.} and Davis, {John W.} and Epstein, {Jonathan I.} and Etzioni, {Ruth B.} and Thomas Farrington and Hemstreet, {George P.} and Kawachi, {Mark H.} and Lange, {Paul H.} and Loughlin, {Kevin R.} and William Lowrance and Paul Maroni and James Mohler and Morgan, {Todd M.} and Nadler, {Robert B.} and Michael Poch and Chuck Scales and Shaneyfelt, {Terrence M.} and Smaldone, {Marc C.} and Geoffrey Sonn and Preston Sprenke and Vickers, {Andrew J.} and Robert Wake and Shead, {Dorothy A.} and Deborah Freedman-Cass",
year = "2015",
month = "12",
day = "1",
doi = "10.6004/jnccn.2015.0181",
language = "English (US)",
volume = "13",
pages = "1534--1561",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "12",

}

TY - JOUR

T1 - Prostate cancer early detection, version 2.2015

T2 - Clinical practice guidelines in oncology

AU - Carroll, Peter R.

AU - Parsons, J. Kellogg

AU - Andriole, Gerald

AU - Bahnson, Robert R.

AU - Barocas, Daniel A.

AU - Castle, Erik P.

AU - Catalona, William J.

AU - Dahl, Douglas M.

AU - Davis, John W.

AU - Epstein, Jonathan I.

AU - Etzioni, Ruth B.

AU - Farrington, Thomas

AU - Hemstreet, George P.

AU - Kawachi, Mark H.

AU - Lange, Paul H.

AU - Loughlin, Kevin R.

AU - Lowrance, William

AU - Maroni, Paul

AU - Mohler, James

AU - Morgan, Todd M.

AU - Nadler, Robert B.

AU - Poch, Michael

AU - Scales, Chuck

AU - Shaneyfelt, Terrence M.

AU - Smaldone, Marc C.

AU - Sonn, Geoffrey

AU - Sprenke, Preston

AU - Vickers, Andrew J.

AU - Wake, Robert

AU - Shead, Dorothy A.

AU - Freedman-Cass, Deborah

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Prostate cancer represents a spectrum of disease that ranges from nonaggressive, slow-growing disease that may not require treatment to aggressive, fast-growing disease that does. The NCCN Guidelines for Prostate Cancer Early Detection provide a set of sequential recommendations detailing a screening and evaluation strategy for maximizing the detection of prostate cancer that is potentially curable and that, if left undetected, represents a risk to the patient. The guidelines were developed for healthy men who have elected to participate in the early detection of prostate cancer, and they focus on minimizing unnecessary procedures and limiting the detection of indolent disease.

AB - Prostate cancer represents a spectrum of disease that ranges from nonaggressive, slow-growing disease that may not require treatment to aggressive, fast-growing disease that does. The NCCN Guidelines for Prostate Cancer Early Detection provide a set of sequential recommendations detailing a screening and evaluation strategy for maximizing the detection of prostate cancer that is potentially curable and that, if left undetected, represents a risk to the patient. The guidelines were developed for healthy men who have elected to participate in the early detection of prostate cancer, and they focus on minimizing unnecessary procedures and limiting the detection of indolent disease.

UR - http://www.scopus.com/inward/record.url?scp=84983122741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983122741&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2015.0181

DO - 10.6004/jnccn.2015.0181

M3 - Article

VL - 13

SP - 1534

EP - 1561

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

IS - 12

ER -